MaaT Pharma
No trades
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 4.52 M EUR, the most of which — 4.52 M EUR — came from its top-performing segment, Microbiome Restoration Therapy, compared to 3.22 M EUR the previous year. The greatest contribution came from France, which accounted for 4.52 M EUR last year, with 3.22 M EUR the year before.
By source
By country